期刊文献+

miR-125b通过下调HAX-1的表达提高CD133^+ SW480细胞对顺铂的敏感性 被引量:2

miR-125b increases sensitivity of CD133^+ colorectal cancer cells to cisplatin by down-regulating HAX-1 expression
下载PDF
导出
摘要 目的:探讨miR-125b在CD133^+结直肠癌细胞中发挥的作用并研究其是否和顺铂的体外治疗有关。方法:用RT-qPCR方法检测miR-125b在常规SW480肿瘤细胞及CD133^+ SW480肿瘤细胞中的表达水平。流式细胞术检测miR-125b和顺铂对SW480细胞系中CD133^+ 细胞比例的影响。MTT法检测miR-125b对顺铂杀伤CD133^+ SW480细胞能力的影响。利用生物信息学及Western blot方法验证miR-125b是否调节CD133^+ SW480细胞中HAX-1的表达。运用JC-1染色、Annexin V染色及Western blot方法研究miR-125b影响顺铂疗效的信号通路的效应。结果:CD133^+ SW480细胞中的miR-125b表达水平显著低于正常结直肠上皮细胞系FHC和常规SW480肿瘤细胞。顺铂体外单独治疗能提高SW480细胞系中CD133^+细胞的比例,然而联用miR-125b模拟物后CD133^+ SW480细胞的比例显著下降。MTT实验结果表明miR-125b可显著增强顺铂对CD133^+ SW480细胞的杀伤活性。Western blot实验表明miR-125b的靶基因可能为HAX-1。miR-125b联合顺铂可引起CD133^+ SW480细胞线粒体膜电位的丧失并诱导线粒体内细胞色素C的释放,进而引起细胞凋亡。转染HAX-1表达载体后miR-125b联合顺铂对CD133^+ SW480细胞的凋亡诱导效应显著降低。结论:miR-125b通过下调HAX-1的表达提高CD133^+结直肠癌细胞对顺铂的敏感性。 AIM: To investigate the role of miR-125b in regulating the sensitivity of CD133 + colorectal cancer cells to cisplatin. METHODS: The expression of miR-125b was detected by RT-qPCR in the routine SW480 cells and CD133 + SW480 cells. Flow cytometry analysis was performed to measure the percentage of CD133 + cell population in the SW480 cell line treated with miR-125b and cisplatin. MTT assay was performed to evaluate the effect of miR-125b on the cisplatin-induced cell death in the CD133 + SW480 cells. Bioinformatics and Western blot were performed to determine whether the expression of HAX-1 was regulated by miR-125b. JC-1 staining, Annexin V staining and Western blot analysis were used to study the pathway of apoptosis in the CD133 + SW480 cells co-treated with miR-125b and cisplatin. RE-SULTS: The expression of miR-125b was significantly lower in the CD133 + SW480 cells than that in the routine SW480 cells and normal colonic epithelial FHC cells. Treatment with cisplatin alone increased the percentage of CD133+ SW480 cell population. However, miR-125b significantly inhibited the enrichment of CD133 + cell population induced by cisplatin. In addition, the results of MTT assay showed that the anti-tumor effect of cisplatin was significantly enhanced when the miR-125b was transfected into the CD133 + SW480 cells. The results of Western blot indicated that the HAX-1 gene was the target of miR-125b. Furthermore, the apoptosis induced by the combination of miR-125b and cisplatin was dependent on the dysfunction of mitochondrial membrane, leading to the release of cytochrome C into the cytoplasm and the subsequently activation of apoptosis in the CD133 + SW480 cells. CONCLUSION : miR-125b increased the sensitivity of CD133 + colo-rectal cancer cells to cisplatin by down-regulating the expression of HAX-1.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2017年第6期1053-1059,共7页 Chinese Journal of Pathophysiology
关键词 miR-125b HAX-1 细胞色素C 顺铂 CD133+结直肠癌细胞 miR-125b HAX-1 Cytochrome C Cisplatin CD133+ colorectal cancer cells
  • 相关文献

参考文献2

二级参考文献21

  • 1Fei Ren,Wei-Qi Sheng,Xiang Du.CD133:A cancer stem cells marker, is used in colorectal cancers[J].World Journal of Gastroenterology,2013,19(17):2603-2611. 被引量:19
  • 2古洁若,黄烽,Jatinderpal Kalsi,余得恩.趋化因子受体CXCR4及其配体SDF-1与强直性脊柱炎发病的相关性研究[J].中国病理生理杂志,2005,21(2):224-229. 被引量:17
  • 3Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer[ J]. Ann Surg, 2006, 244(2) :254 -259. 被引量:1
  • 4Saad RS, Kordunsky L, Liu YL, et al. Lymphatic microvessel density as prognostic marker in colorectal cancer [J]. Mod Pathol,2006,19(10) :1317 -1323. 被引量:1
  • 5Fidler IJ. The pathogenesis of cancer metastasis: the ' seed and soil' hypothesis revisited [ J ]. Nat Rev Cancer, 2003, 3(6) :453 -458. 被引量:1
  • 6Ben- Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors [ J ]. Clin Exp Metastasis, 2008, 25(4) :345 -356. 被引量:1
  • 7MUller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis [ J ]. Nature, 2001,410(6824) :50 -56. 被引量:1
  • 8Gassmann P, Haier J, Schlater K, et al. CXCR4 regulates the early extravasation of metastatic tumor cells in vivo[J]. Neoplasia, 2009, 11(7):651 -661. 被引量:1
  • 9Garber K. First results for agents targeting cancer - related inflammation[J]. J Natl Cancer Inst, 2009, 101 (16) : 1110-1112. 被引量:1
  • 10Wang J, Lu Y, Wang J, et al. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway[ J ]. Cancer Res,2008, 68 (24) : 10367 - 10376. 被引量:1

共引文献11

同被引文献1

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部